Targeted cisplatin
WebThe structure of the [Pd 2 L 4 ⊃(cisplatin) 2](BF 4) 4 host–guest adduct has been confirmed by 1 H NMR spectroscopy, HR-ESMS and X-ray crystallography. Additionally we have demonstrated that the cage–cisplatin host–guest adduct can be quantatively disassembled upon the addition of a competing ligand , releasing the cisplatin guest. WebApr 12, 2024 · Three mechanisms define cisplatin’s direct involvement, demonstrating the chemo-resistant tumor cell phenotype: pre-target, on-target, and post-target resistance [20,21,22]. The first is characterized by reduced intracellular accumulation and increased cisplatin sequestration caused by GSH and other scavengers.
Targeted cisplatin
Did you know?
WebApr 11, 2024 · Testicular cancer, also known as testicular germ cell tumors (TGCT), is the most common type of cancer in young men. When treated with cisplatin, the tumor cells stop growing and die. This is ...
WebJun 30, 2013 · Targeted knockdown of NBK/BIK significantly reduced the proapoptotic effects of MLN4924/cisplatin, indicating that this BH3-only protein is a critical regulator of sensitivity to this combination (Fig. 5C and D). We are currently investigating the mechanisms that underlie the ability of MLN4924 and cisplatin to significantly increase … WebJan 26, 2024 · The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin elicited a significant improvement in overall survival (OS) vs gemcitabine and cisplatin …
WebCisplatin is a chemotherapy medication used to treat a number of cancers. These include testicular cancer, ovarian cancer, cervical cancer, bladder cancer, head and neck cancer, … WebSep 24, 2024 · Cisplatin (CDDP) is the drug of choice against different types of cancer. However, tumor cells can acquire resistance to the damage caused by cisplatin, generating genetic and epigenetic changes that lead to the generation of resistance and the activation of intrinsic resistance mechanisms in cancer cells. Among them, we can find mutations, …
WebJan 18, 2024 · As a target of cisplatin, GG dinucleotides are enriched 5–8 nt upstream of the 3′-end of the reads across all samples (Supplementary Figures 10 and 11 ), which is consistent with previous...
WebTargeted nanomedicine shows great promise in delivering cisplatin for maximizing efficacy while minimizing off-target toxicity. This article surveyed the recent progress and challenges of targeted nanomedicine in managing resistance and toxicity of cisplatin in both fundamental and clinical aspects. Particularly, we focused on three major ... nbc lx teamWebApr 6, 2024 · Cisplatin (DDP) is a common therapeutic option for non-small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. … maroma beach mxWebApr 13, 2024 · Gene scissors find target for testicular cancer therapy Bonn researchers uncover contribution of protein degradation processes to cisplatin resistance in germ cell tumors: Cisplatin is used successfully in the chemotherapy of testicular cancer. maro mountainWebThe discrepancy of surface receptors on cancerous and non-cancerous cells has been regarded as the mainstay of cancer-targeted therapy. However, due to the heterogeneity of tumor cells and the insufficient levels of receptors on the tumor cell surface, the success of cancer cell-targeted therapies is largely Bioorthogonal and click chemistry: Celebrating … nbc macy day parade streamWebNov 15, 2024 · Although effective in promoting survival, cisplatin can cause potentially lasting adverse effects, including hearing loss and kidney damage. Physicians have increasingly been turning to cetuximab plus radiotherapy after one study suggested cetuximab conferred a survival benefit of similar magnitude as cisplatin when combined … marom dolphin coversWebNiraparib (Zejula) may be used in some situations to treat ovarian cancer. In women with or without a BRCA gene mutation: Niraparib might be used as maintenance treatment for … maronan metals optionsWebThe discrepancy of surface receptors on cancerous and non-cancerous cells has been regarded as the mainstay of cancer-targeted therapy. However, due to the heterogeneity … maron cream blend stick